1997
DOI: 10.1016/s0165-2478(97)85808-7
|View full text |Cite
|
Sign up to set email alerts
|

CD146 (MUC18/MCAM): An activation antigen of human T lymphocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
11
0

Year Published

1998
1998
2019
2019

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 0 publications
1
11
0
Order By: Relevance
“…However, the expression by T cell lines is in keeping with a recent report that MUC18 is expressed on activated T cells. 30 Our findings are reinforced by the detection of MUC18 on cells from patients with acute leukemia of lymphoid (T or B) or myeloid lineage, as well as some with chronic B cell lymphoproliferative disorders. The cells tested came from patients of various ages and at different stages of disease progression.…”
Section: Figuresupporting
confidence: 60%
See 1 more Smart Citation
“…However, the expression by T cell lines is in keeping with a recent report that MUC18 is expressed on activated T cells. 30 Our findings are reinforced by the detection of MUC18 on cells from patients with acute leukemia of lymphoid (T or B) or myeloid lineage, as well as some with chronic B cell lymphoproliferative disorders. The cells tested came from patients of various ages and at different stages of disease progression.…”
Section: Figuresupporting
confidence: 60%
“…19 While early studies suggested a lack of expression on normal peripheral blood lymphocytes or human leukemic cell lines, 18 MUC18 has recently been recognized as an activation antigen on human T lymphocytes. 30 In addition to cloning data, we were able to immunoprecipitate a 100-110 kDa protein from the pre-B cell line NALM-6 which is comparable to the 113 kDa protein of MUC18 precipitated from a melanoma cell line. 29 This suggests that the mature protein exists in a glycosylated form, as is the case for other members of the IgSF such as VCAM-1 13 and NCAM.…”
Section: Figurementioning
confidence: 68%
“…MUC18-mediated adhesion between melanoma cells and endothelial cells, via an unknown heterophilic ligand, may be important for the movement of melanoma cells in and out of the tumor vasculature [34,47,50,59]. Activated peripheral T lymphocytes also express MUC18, with an increased capacity to bind endothelial cells that contributes to T-cell extravasation and/or homing [10,40,44]. Overall these observations indicate that interactions between MUC18-positive tumor cells and endothelial cells (and activated T-lymphocytes), may play an important role in (cutaneous and uveal) melanoma hematogenous spread and immunoregulation.…”
Section: Discussionmentioning
confidence: 99%
“…Melanoma cells seeded at clonal cell densities show poor survival and growth in growth factor-depleted medium (unpublished observation), suggesting that cell ± cell adhesion provides the cells with a major survival and growth advantage. Mel-CAM has also been detected on activated T cells (Pickl et al, 1997), smooth muscle (Shih et al, 1994) and vascular endothelial cells (Bardin et al, 1996;St Croix et al, 2000;Sers et al, 1994), although its function in these cells is unclear. It has been reported that activation of Mel-CAM leads to tyrosine phosphorylation of p125 FAK and of paxillin, and is associated with p59 fyn (Anfosso et al, 1998).…”
Section: Discussionmentioning
confidence: 99%